Managing an outpatient parenteral antibiotic therapy team: Challenges and solutions

Therapeutics and Clinical Risk Management

Volumn 10, Issue 1, 2014, Pages 459-465

  Halilovic, Jenana ^a   Christensen, Cinda L ^b   Nguyen, Hien H ^c  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

OPAT; Program management; Quality; Safety

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; DAPTOMYCIN; GLYCOPEPTIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; CLINICAL PRACTICE; CONTINUOUS INFUSION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL DISEASE; GOOD CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SERVICE; HEART FAILURE; HEMATOLOGIC DISEASE; HOME; HOME CARE; HUMAN; KIDNEY FAILURE; OUTPATIENT; OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY; PRACTICE GUIDELINE; REVIEW; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84903139281     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S48906     Document Type: Review

References (19)

1. Gilchrist M, Franklin BD, Patel JP. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother. 2008;62(1):177-183.
2. Muldoon EG, Snydman DR, Penland EC, Allison GM. Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence. Clin Infect Dis. 2013;57(3):419-424.
3. Tice AD, Rehm SJ, Dalovisio JR, etal; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651-1672.
4. Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39(5):407-413.
5. Dryden M, Saeed K, Townsend R, etal. Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemother. 2012;67(9):2289-2296.
6. Heintz BH, Halilovic J, Christensen CL. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center. Ann Pharmacother. 2011;45(11):1329-1337.
7. Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM. Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. J Hosp Med. 2012;7(5):365-369.
8. Chapman AL, Seaton RA, Cooper MA, etal; BSAC/BIA OPAT Project Good Practice Recommendations Working Group. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053-1062.
9. Seaton RA, Barr DA. Outpatient parenteral antibiotic therapy: principles and practice. Eur J Intern Med. 2013;24(7):617-623.
10. Chary A, Tice AD, Martinelli LP, Liedtke LA, Plantenga MS, Strausbaugh LJ; Infectious Diseases Society of America Emerging Infections Network. Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis. 2006;43(10):1290-1295.
11. Huck D, Ginsberg JP, Gordon SM, Nowacki AS, Rehm SJ, Shrestha NK. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. J Antimicrob Chemother. 2014;69(1):228-233.
12. Shrestha NK, Mason P, Gordon SM, etal. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study. J Antimicrob Chemother. 2014;69(5):1407-1415.
13. Slavik RS, Jewesson PJ. Selecting antibacterials for outpatient parenteral antimicrobial therapy: pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet. 2003;42(9):793-817.
14. Petroff BJ, Filibeck D, Nowobilski-Vasilios A, Olsen RS, Rollins CJ, Johnson C. ASHP guidelines on home infusion pharmacy services. Am J Health Syst Pharm. 2014;71(4):325-341.
15. Allison GM, Muldoon EG, Kent DM, etal. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis. 2014;58(6):812-819.
16. Duncan CJ, Barr DA, Ho A, Sharp E, Semple L, Seaton RA. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis. J Antimicrob Chemother. 2013;68(7):1650-1654.
17. Seaton RA, Sharp E, Bezlyak V, Weir CJ. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents. 2011;38(3):243-248.
18. Eaves K, Thornton J, Chapman AL. Patient retention of training in self-administration of intravenous antibiotic therapy in an outpatient parenteral antibiotic therapy service. J Clin Nurs. 2014;23(9-10): 1318-1322.
19. Nguyen HH. Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis. 2010;51 Suppl 2: S220-S223.